As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

Few large-cap dividends generate as much skepticism as Pfizer (NYSE:PFE | PFE Price Prediction). The stock trades at $24.37, ...

A group of public health professionals, scientists and others that sued the U.S. Food and Drug ​Administration to obtain COVID-19 vaccine approval records has asked a federal judge to order the ...

The late Jane W. Smith, who died at 107, lived for more than 60 years at a lakefront house in Palm Beach, which just sold for ...

Pfizer is deeply out of favor on Wall Street, which could be a huge opportunity for long-term dividend investors.

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending a ...

Pfizer has ​been dismissed as a defendant in a sweeping antitrust lawsuit in which most U.S. states ‌accused dozens of ...

Lexicon Pharmaceuticals operates as a contender among biotech stocks by utilizing gene science to develop treatments for chronic conditions. The company primarily focuses on its commercial product, ...

That should be all the information you need to solve for the What someone may attempt to explain in a long, drawn-out description crossword clue! Be sure to check more clues on our Crossword Answers.

Pfizer Inc. is pulling back the curtain on its obesity ambitions, releasing new data on an experimental weight-loss shot and outlining a strategy to claw its way into a leadership position in the ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...